S 708referred119th Congress

RESTORE Patent Rights Act of 2025

Introduced Feb 25, 2025Senate billPolicy area: CommerceLast action Feb 25, 2025Sponsor: Christopher A. Coons(D-DE)

tradeCommerce

Judiciary Committee

Ask about this Build timeline Compare Export source pack

Official Congress record Open in Network Lab Trace connections

Official summaryUpdated Feb 25, 2025

What the bill does

Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 or the RESTORE Patent Rights Act of 2025 This bill establishes a rebuttable presumption for injunctive relief in patent infringement cases. Specifically, if a court enters a final judgment finding infringement of a right secured by patent, the patent owner shall be entitled to a rebuttable presumption that the court should grant a permanent injunction with respect to that infringing conduct. (In 2006, the U.S. Supreme Court held in eBay v. MercExchange that patent holders do not have an automatic right to a permanent injunction in a patent infringement case.)

Latest official action

Read twice and referred to the Committee on the Judiciary.

Lobbying Filings Citing It

$41.6M

Reported on Those Filings, All Issues

Lobbying Clients

Recorded Votes

Timeline

Feb 25, 2025bill

Bill introduced

Apr 21, 2025lobbying

Lobbying filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Apr 21, 2025lobbying

Lobbying filed by AMAZON.COM SERVICES LLC

Jul 21, 2025lobbying

Lobbying filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Jul 21, 2025lobbying

Lobbying filed by APPLE INC

Jul 22, 2025lobbying

Official Congressional Actions

Feb 25, 2025IntroReferral

Read twice and referred to the Committee on the Judiciary.

Judiciary Committee

View official action

Feb 25, 2025IntroReferral

Introduced in Senate

View official action

Lobbying Activity

Registrant	Client	Amount	Filed	Period	Issues
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	$12.9M	Apr 21, 2025	2025Q1	BUDCPTHCR
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	$7.6M	Jul 21, 2025	2025Q2	BUDCPTHCR

About this page

The lobbying table lists Senate LDA quarterly reports (LD-2) that cite this bill by number and cover a quarter of the 119th Congress. An LD-2 names a bill as “H.R. 1234” with no Congress, so a report on another Congress, which can only concern a different bill with the same number, is left out, even when it was filed after this Congress began. The amount is what the registrant reported for the whole filing, across every issue on it, not spending on this bill. Official actions and the bill summary come from Congress.gov, and votes from the roll-call record. This page no longer pairs the bill with members' stock trades: matching lobbying clients to traded companies by name, and trades to a bill by date, is not something the records establish.